NR 565 Pharm Midterm Actual Questions and Correct Answers
Q1
CYP2C9
Answer: Decrease warfarin doseTest for gene VCORC1 mutation
Q2
Schedule I
Answer: no accepted medical use in the US it may not be prescribed.heroin,various opium
derivatives,hallucinogenic substances
Q3
Schedule II
Answer: No refills, no telephone ordersNarcotics, Stimulants, Depressants
Q4
Schedule III
Answer: Drugs in this category are considered to be at moderate or low risk for physical
dependence, and with
current reasons for medical useAnabolic steroids, most barbituates and ketamine Must prescribe
every
6 months, can be by phone
Q5
Schedule IV
Answer: Abuse potential exists, but less than Sch III.Examples are: Ambien, Darvocet and
Lorazepam
Q6
Schedule V
Answer: Not always necessary to have a prescriptionLoperamide, diphenoxylate and cough
medicine with less
than 200mg/100 ml pregabalin
Q7
Preclinical research
Answer: Research of drug potential, animal testing, preparation for human testing
, Q8
Phase I
Answer: Initial clinical safety studies in humans. May be as few as 10 subjects, often healthy
volunteers
Q9
Phase II
Answer: The study drug or treatment is given to a larger group of people (100-300) to see if it is
effective and to
further evaluate its safety
Q10
Phase III
Answer: The study drug or treatment is given to large groups of people (1,000-3,000) to confirm
itseffectiveness,
monitor side effects, compare it to commonly used treatments, and collectinformation that will
allow
the drug or treatment to be used safely
Q11
Adrenergic agonists
Answer: Drugs that stimulate and mimic the actions of the sympathetic nervous system. Also
calledsympathomimetics
Q12
alpha 2 agonists
Answer: Decrease sympathetic impulses from the CNS to the heart and arterioles, causing
vasodilation Lowers
blood pressure, diuretic may be neededClonodine, Methyldopa, GuanabenzSE: dry mouth, urinary
retention, weight gain etc
Q13
Adrenergic Antagonist
Answer: A drug that blocks the actions of the sympathetic nervous system
Q1
CYP2C9
Answer: Decrease warfarin doseTest for gene VCORC1 mutation
Q2
Schedule I
Answer: no accepted medical use in the US it may not be prescribed.heroin,various opium
derivatives,hallucinogenic substances
Q3
Schedule II
Answer: No refills, no telephone ordersNarcotics, Stimulants, Depressants
Q4
Schedule III
Answer: Drugs in this category are considered to be at moderate or low risk for physical
dependence, and with
current reasons for medical useAnabolic steroids, most barbituates and ketamine Must prescribe
every
6 months, can be by phone
Q5
Schedule IV
Answer: Abuse potential exists, but less than Sch III.Examples are: Ambien, Darvocet and
Lorazepam
Q6
Schedule V
Answer: Not always necessary to have a prescriptionLoperamide, diphenoxylate and cough
medicine with less
than 200mg/100 ml pregabalin
Q7
Preclinical research
Answer: Research of drug potential, animal testing, preparation for human testing
, Q8
Phase I
Answer: Initial clinical safety studies in humans. May be as few as 10 subjects, often healthy
volunteers
Q9
Phase II
Answer: The study drug or treatment is given to a larger group of people (100-300) to see if it is
effective and to
further evaluate its safety
Q10
Phase III
Answer: The study drug or treatment is given to large groups of people (1,000-3,000) to confirm
itseffectiveness,
monitor side effects, compare it to commonly used treatments, and collectinformation that will
allow
the drug or treatment to be used safely
Q11
Adrenergic agonists
Answer: Drugs that stimulate and mimic the actions of the sympathetic nervous system. Also
calledsympathomimetics
Q12
alpha 2 agonists
Answer: Decrease sympathetic impulses from the CNS to the heart and arterioles, causing
vasodilation Lowers
blood pressure, diuretic may be neededClonodine, Methyldopa, GuanabenzSE: dry mouth, urinary
retention, weight gain etc
Q13
Adrenergic Antagonist
Answer: A drug that blocks the actions of the sympathetic nervous system
